Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116776 | SCV000150752 | benign | not specified | 2017-04-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000116776 | SCV000167788 | benign | not specified | 2013-04-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000116776 | SCV000312060 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000457650 | SCV000563240 | benign | Cortical dysplasia-focal epilepsy syndrome | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313872 | SCV000847891 | benign | Inborn genetic diseases | 2016-05-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |